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Abstract
The testicular yolk sac tumor (TYST) is the most common neoplasm originated from germ cells differentiated
abnormally, a major part of pediatric malignant testicular tumors. The present study aimed at developing and
validating the in vitro and vivo models of TYST and evaluating the sensitivity of TYST to treatments, by cloning
human TYST cells and investigating the histology, ultra-structure, growth kinetics and expression of specific
proteins of cloned cells. We found biological characteristics of cloned TYST cells were similar to the yolk sac tumor
and differentiated from the columnar to glandular-like or goblet cells-like cells. Chromosomes for tumor
identification in each passage met nature of the primary tumor. TYST cells were more sensitive to all-trans-retinoic
acid which had significantly inhibitory effects on cell proliferation. Cisplatin induced apoptosis of TYST cells through
the activation of p53 expression and down-regulation of Bcl- expression. Thus, we believe that cloned TYST cells
and the animal model developed here are useful to understand the molecular mechanism of TYST cells and
develop potential therapies for human TYST.
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Introduction
The testicular yolk sac tumor (TYST) is the most com-
mon neoplasm originated from germ cells differentiated
abnormally [1], while germ cell tumors in the testis
account for approximately 60-75% of pediatric malig-
nant testicular tumors. The yolk sac tumor as endoder-
mal sinus tumor is a common malignant tumor
accounting for 1-2% of cancers in men and one of the
most common types of cancer in young men between
15-35 ages. Of them, the TYST mainly occurs in neo-
nates and infants, different from adolescences or adults
who composed of multiple germ cells and having own
biological characters [2].
T h eT Y S Ti ss t i l lah i g h l ym a l i g n a n tn e o p l a s mw i t h
poor prognosis, increased resistance to chemotherapy,
recurrence after initial chemotherapy or surgery, and
the side effects of chemotherapeutics, even though the
survival rate of patients with TYST was improved after
surgical resection or platinum-based combination che-
motherapy, e.g. cisplatin, etoposide and bleomycin [3].
The regulation of cell differentiation from immature
malignant tumor cells to mature was suggested as a
potential therapy for tumors [4]. Conventional radio-
therapy and/or chemotherapy were found to suppress
the bone marrow and immune function through influen-
cing cell phenotypes [5]. The cell apoptosis is closely
related with the tumorigeness, tumor development and
insensitivity of chemotherapy/radiation therapy [6].
There are limited studies on human TYSTs, although
YST has been studies in cells from male murine embry-
onal carcinoma in vitro [7] and ovarian YST cell lines
[8]. The present studies aimed at establishing the animal
model of TYST and the human TYST cell line and eval-
uating the characteristics of the disease and bio-function
of human TYST cells. The present study evaluated the
role of ATRA as an inducer of differentiation in a vari-
ety of tumor cells in the growth TYST cell lines in vitro
and explored the molecular mechanism of TYST cell
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TYST tissues were sampled children with TYST, aging
about 2-3 years-old, during the testicular surgery, with-
out any radiotherapy or chemotherapy. The study proto-
col and informed consent of the sampling for scientific
research were approved by The Ethical Committee of
Clinical Research of Second Affiliated Hospital of Wenz-
hou Medical College. Informed written consents were
approved from guardians on the behalf of the children
participants involved in the study. Tumors with dia-
meters about 50-70 mm and without the encapsulation
were severely adhered with the surrounding tissues.
Plasma levels of alpha-fetoprotein were above 1200 ng/
ml, corresponded with the normal reference value of 0-7
ng/ml. TYST samples were positive in immunohisto-
chemical staining against cytokeratins and alpha-
fetoprotein.
A xenograft tumor model
Male BALB/C mice with the autosomal recessive nude
gene in homozygous (nu/nu), aging four weeks, were
purchased from Shanghai Experimental Animal Center
of Chinese Academy of Sciences. Mice were housed and
maintained in individual ventilation cabinets under spe-
cific pathogen-free conditions with constant temperature
at 24°C. Animal studies were approved by the local ethi-
cal committee for animal care according to international
guidelines and regulations for use and care of animals.
Human tumor specimen from the surgery was washed
immediately and sliced into near 1 mm
3 masses under
sterile conditions. Each piece of tumor mass was
implanted hypodermically into the unilateral inguinal
region in mice. Tumors growth was observed periodi-
cally and mice were terminated until the tumor grew to
2-3 cm in diameter. Tumors were exteriorized and
implanted in new mice as described, and then perpetu-
ated in mice by consecutive passages from the primary
tumor. This study was carried out in strict accordance
with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Insti-
tutes of Health. The protocol was approved by the Ethi-
cal Committee on Animal Experiments of the Wenzhou
Medical College. All surgery was performed under
anesthesia of sodium pentobarbital to minimize
suffering.
Measure of tumor growth
The latent period and growth rate of tumor were
recorded daily. Volumes and exponential function of
tumors were measured weekly from the day when
tumors reached 3 mm in diameter. Volume of tumors
(Vt) was calculated in the formula: Vt = π(b2 × a)/6 (b
and a represent the minimal and maximal diameter in
millimeters, respectively) and exponential function (K)
was calculated as growth rate: K = (InVt-InV0), and
then doubling time: Td = In2/K.
TYST morphologies
Tumors were obtained from surgical resection, fixed in
10% formalin, embedded with paraffin, and sectioned in
a thickness of 4 um. Slices were then de-paraffinized,
rehydrated, and finally stained with hematoxylin and
eosin. The tumor morphology was analyzed and
observed under light microscope. For ultrastructural
analysis, tumors were cut into small pieces about 1
mm
3, immersed and fixed in a solution of 4% glutaralde-
hyde (pH 7.3, 4°C). Fixed samples were washed in phos-
phate buffer twice and then post-fixed in 1% osmium
tetroxide (Polysciences Inc., New Orleans, LA, USA) for
1 hr. Samples were then rinsed extensively in distilled
water, dehydrated in a graded series of ethanol,
embedded in Eponate 812 resin (Ted Pella Inc., Redding,
USA), and dried by heat with a graded temperature.
Sections of 50 nm were then cut with a Leica Ultracut
UCT ultramicrotome (Leica Microsystems Inc, LKB-II,
Germany), stained with 3% solution of uranyl acetate
and lead citrate, and mounted on mesh grids. Digital
pictures (2048 × 2048 pixels, 4 MB, and uncompressed
grayscale Tiff files) were obtained using a high resolu-
tion digital camera MegaViewIII (SIS
®) connected to the
TEM, and observed at electron microscope with an
acceleration voltage of 80 kV, in JEOL JEM-1230
(Japan).
Immunohistochemistry
TYST Tumors were fixed in formalin for approximately
10 hrs, embedded in paraffin overnight in a routine
fashion, and cut into sections at the thickness of 4 μm.
Sections were subsequently boiled for 10 minutes in 10
mM citrate (pH 6.0), after being dewaxed and incubated
in methanol containing 0.3% H2O2 for 15 minutes. Sec-
tions were digested with 0.25% pepsin (Sigma) dissolved
in 0.1 M HCl for 15 minutes at 37°C, blocked for 30
minutes in PBS containing 5% normal mouse serum
(Jackson Immunoresearch, Newmarket, UK), and then
incubated with antibodies again alpha-fetoprotein (AFP,
goat anti-mouse alpha-fetoprotein polyclonal antibody;
R&D Systems, Minneapolis, USA), placental alkaline
phosphatase (PLAP, anti-placental alkaline phosphatase
antibody, Abcam, Cambridge, UK), or cytokeratins (CK,
mouse anti-mouse cytokeratin 10 monoclonal antibody,
unconjugated, clone Spm262; Thermo Fisher Scientific,
Rockford, IL, USA) for 2 hours, while HRP-conjugated
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perature. TYST sectionsw e r es t a i n e du s i n g3 , 3 ’-diami-
nobenzidine and alternatively counterstained with
haematoxylin. The concentrations of primary antibodies
were used at 1:100. TYST sections were observed and
photographed under an inverted Olympus phase con-
trast microscope equipped with a digital camera (Olym-
pus dp71, Japan). For the analysis of positive cellular
numbers (PCN) and the optical density (OD), total 20
hotspot fields were captured for each section in viable
zones at × 400 using a camera and analyzed by image-
pro plus 6.0 software. Semi-quantitative analyses of
immunohistochemical staining were performed as the
formula of expression values (EP): = PCN × OD.
Chromosomes analysis
Fresh TYST samples were obtained, washed with PBS
twice, sliced into small particles, and then put into cul-
ture medium (RPMI 1640, L-glutamine 2 mM, penicillin
100 units/ml, streptomycin 100 mg/ml, colcemid 0.1 pg/
ml) without serum. These particles were put into colchi-
cine and incubated in the water bath at 37°C for 1 h.
Tumor cells were centrifuged, fixed, and detected in G-
banding. Chromosomes were counterstained and reverse
banded by mounting the slides in Citifluor antifade AFl
(Citifluor Ltd) containing 2.5 μg/ml of DAPI and 0.5 μg/
ml of propidium iodide, as described in previous studies
[9]. Hybridised slides were assessed using a Nikon Opti-
phot fluorescence microscope with a × 100. Images
were recorded as grey levels at two detectors (detector
1, 500 to 560 nm; detector 2 < 600 nm) of an MRC 600
confocal scanning head (Biorad) and displayed in a
pseudo-color (FITC fluorescence in green, PI fluores-
cence in red). The band location of FITC signal was
determined by toggling the FITC signal to allow the
banding pattern beneath the signal.
Primary culture of TYST cells and establishment of cell
line
TYST tissues were harvested, immediately washed by D-
Hank’s solution (NaCl 8.0 g, KCl 0.2 g, Na2HPO4·H2O
1.56 g, KH2PO4 0. 2 g in 1 L distilled water) in order to
clean up blood and mucus in surface, and then sliced
into 1 mm
3 pieces. Sliced tissues incubated in Dulbec-
co’s modified Eagle medium (GibcoBRL, Grand Island,
NY, USA) solution containing 20% fetal calf serum at
37°C. The first generation of cells was passed when cells
grew to cover the 80% bottom of the culture bottle in
14 days, and the second passage in 8 days. From the
third generation of cells, the average passage time was 3
to 4 days until 25 generation and cells grew stably and
kept the primary characteristics. Cells from the 8th gen-
eration were used in the study and the survival rate of
recovery cells from freezing reached about 80% and
their morphologies were observed under inverted micro-
scope, light microscope and electron microscope,
respectively.
Bio-function measurement
Cell growth curve was drawn by counting and recording
cell density of three holes, of which each was operated
with 3 times interval 24 hours during days 1-8. Cells
were diluted at the density of 2 × 10
4 per ml and inocu-
lated into 24-well plate. The single cell suspension was
made and cell doubling time was monitored. Cytoge-
netic analysis was performed in TYST cells in the loga-
rithmic growth phase, after cells were treated with
trypsin, fixed with methanol-acetic acid solution, and
stained with trypsin-Giemsa. About 100 cells in meta-
phase and the number of chromosomes and its modes
were accounted [10], after then pictures were captured
by Applied Imaging Software with G-banding analysis.
The expression of AFP and beta-subunit human chorio-
nic gonadotrophin (b-hCG) was measured by immuno-
cytochemical staining according to the manufacture
recommendation.
DNA ploidy analysis
Cellular DNA ploidy and cycle were detected by flow
cytometry, as described previously [11]. Briefly, DNA
ploidy was analyzed after the cell sorting, after the flow
cytometry was calibrated with fluorescent DNA-Check
Beads (Coulter) to obtain a percentage half peak coeffi-
cient of variation (%HPCV). Histograms were recorded
for a minimum of 10,000 nuclei, according to the guide-
line criteria drawn up in the DNA Cytometry Consensus
Conference [12]. The exclusive criteria were the coeffi-
cient of variation greater than 8% or background debris
constituting more than 20%. DNA diploidy was defined
b yt h ep r e s e n c eo fas i n g l eG 0 / G 1p e a kt oah i s t o g r a m .
A tumor was considered as aneupoid if a histogram had
two separate G0/G1 peaks. The DNA index was calcu-
lated from the ratio of the model channel numbers of
aneuploid peaks to the modal channel numbers of the
diploid peak. Intratumoral DNA heterogeneity was
defined by the presence of both DNA diploidy and
aneuploidy with a tumor, or by the presence of multiple
stem lines in aneuploid patterns. DNA histograms were
assessed using MultiCycle software version 2.5 (Coulter)
to determine the SPF. A polynomial modeling system
was used for cell cycle analysis.
Cloning procedure
Cells at the 26th passage were cultured in soft agar and
the rate of cell clones formation was tested. Briefly, cells
were cultured in the medium containing high glucose
Dulbecco’s modified Eagle medium supplemented with
10% fetal bovine serum (Hyclone, Utah, USA). Two days
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sterile tube (Corning Incorporated, Corning, NY, USA),
centrifuged at 2000 rpm for 10 min. Cells grew to
approximately 80% confluence, and the culture flask was
placed in 4 refrigerator for 4 h to synchronize the cells,
followed by incubation overnight. The single cell sus-
pension was prepared after trypsinization (2.5 g/L tryp-
sin, Difco, prepared in Ca
2+ and Mg
2+ free Hanks
solution d-Hanks). The cell viability was confirmed by
trypan blue exclusion, and cloning procedure was per-
formed using the limited dilution method [6]. The
cloned cells were preserved in culture medium contain-
ing 100 g/L dimethyl sulfoxide (DMSO, Sigma Chemical
Co, St Louis, MO, USA), and stored in liquid nitrogen
till used for in vivo screening.
Role of retinoic acid
Cloned TYST- cells were randomly divided into five
groups (n = 10/group) treated with vehicle (group 1) or
ATRA at concentrations of 0.01, 0.1, 1.0 or 5.0 uM
(groups 2-5). ATRA was solved in ethanol at the start
and diluted with PBS at the final concentration of 0.1%
as vehicle. Cells were seeded in 6-well culture plates at
2×1 0
4 for 24 hours and the original medium was
replaced by the different concentrations of ATRA solu-
tion. Cells growth was monitored under inverted micro-
scope daily for 7 days. Inhibitory effects of ATRA on
TYST cell proliferation were detected by MTT assay at
24, 48 and 72 hours, respectively. The absorbency was
measured with the colorimetric microplate reader at the
w a v e l e n g t ho f5 7 0n m .T h ei n h i b i t o r yr a t ew a sc a l c u -
lated as the following formula: (%) = (1- experimental
control group OD/blank control group OD) × 100%.
The expression of retinoic acid receptor b (RAR-b)i n
cells was measured by RT-PCR, after total RNAs were
extracted in each experimental group, according to
manufacture’s protocol. The synthesis of cDNAs was
followed by reverse transcriptase kit protocol. Human
RAR–b primer sequences include: forward primer 5’-
GAGGACTGGGATGCCGAGAA-3’ and reverse primer
5’-TTGACCCAAACCGAATGGC-3’; and human b-
actin: forward primer 5’-TCGACAGCTCCGGCAT-3’
and reverse primer 5’-AAGGTGTGGTGCCA-
GATTTTC-3’. Twenty-two cycles of amplification with
denaturation at 94°C, annealing at 60°C and extension at
72°C for 60s each, were carried out after the initial pre-
denaturation at 95°C for 5 min. The relative expression
of targeted mRNA = the product of targeted mRNA
with the volume of gary/the product of b-actin with the
volume of gray.
Role of cisplatin
Cloned TYS cells at the 6th passage were treated with
cisplatin at the concentration of 2 μg/ml for 12, 24, 48
and 72 hours, respectively. Acridine Orange/Ethidium
Bromide (AO/EB) staining fluid at the concentration of
100 mg/L was added into 96-wells at the volume of 20
μl. Cells were incubated at dark for 20 min and
observed under fluorescence microscope. Cell apoptosis
was analyzed with terminal deoxynucleotidyl transferase-
mediated biotin-dUTP nick end labeling (TUNEL) stain-
ing (Merck). Briefly, specimens were incubated with
proteinase K at 20 μg/ml for 15 min at room tempera-
ture and washed with PBS for 5 min thrice. Sections
were blocked with 3% bovine serum albumin and 20%
fetal calf serum solution for 30 min, and incubated with
TUNEL reaction mixture of TdT and dUTP (1:9) at 37°
C for 1 h. Finally, samples were stained with DAB under
control of microscope, and counterstained with hema-
toxylin for 1 min. Total five fields were captured for
each section under microscope. The apoptotic index
(AI) = the positive cell numbers/total cell numbers.
Expression of AFP, P53 and Bcl-2 proteins was detected
with immunohistochemical staining. Mouse monoclonal
antibodies of AFP, P53 and Bcl-2 were diluted with
1:100. Positive cellular numbers, optical density, and
total ten fields captured for each section in viable tissue
zones using a camera (×400, Nikon Digital Sight DS-L2,
Japan), were analyzed by Image-pro plus6.0 software,
respectively. The semi-quantitative = optical density ×
cellular numbers.
Statistical analysis
Data are presented as means ± standard deviation. All
experiments were performed twice and 3-5 animals in a
group were randomly allocated into each study. After
statistical analysis demonstrated no significance between
studies, the results from the same group (n = 6-10)
were pooled. The difference between groups and time
points was calculated using the unpaired, two-tailed Stu-
dent t-test after the analysis of one-way ANOVA. Inhi-
bitory effects (%) were calculated as the formula:
inhibitory rate (%) = [(values of MMT density in differ-
ent time points treated with different concentrations of
inhibitors - values of MMT density in different time
points treated with vehicle) - values of MMT density in
different time points treated with vehicle] × 100. A p-
value of less than 0.05 was considered significant.
Results
Average volumes of tumor driven from the primary gen-
eration, the first generation and the second generation
of TYST cells were increased, as shown in Figure 1A.
Tumor cell volumes of three generations started to
show different from the 10 cycles. Consecutive trans-
plantation of total 7 generations into the subcutaneous
inguinal region of nude mice was performed during 15
months. The rate of tumor formations was 20, 40 and
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and reached 100% from the generation four and on after
the subcutaneous transplantation (Figure 1B). The aver-
age period of tumor formation was 32 days and the
maximal time of tumor growth was 192 days in mice.
Tumor could grow to about 32 × 28 mm
3 in volume, of
which some had the ulceration and necrosis on the sur-
face of TYST and lead to cachexia in nude mice. All
tumors represented the substantial neoplasm without
cystic or mixed ones.
Tumors and internal organs, like liver and lungs, were
harvested and stained immediately after tumor-bearing
mice were sacrificed (Figure 1C). TYST cells had
enlarged volume, obvious heteromorphism, large nucleo-
lus with stained deeply and disordered, abundant cyto-
plasm with pale staining. The nuclei appeared round or
Figure 1 Average volumes of tumor driven from the primary generation, the first generation and the second generation of testicular
yolk sac tumor (TYST) cells were compared with the number of cell cycles (A). The tumor was formed from the generation four of TYST
cells and on after the subcutaneous transplantation (B). Histogram of tumor formed from cloned TYST cells stained with HE (C, × 400).
Ultrastructure of cloned TYST cells with basement membrane materials, oval and enlargement nuclei, and glandular-like structures between cells
(D, × 5000).
Zhao et al. Journal of Translational Medicine 2012, 10:46
http://www.translational-medicine.com/content/10/1/46
Page 5 of 12oval, arranged like the glomerular structure and loose
mesh-like structure. Some of TYST cells with the papil-
lary-like structure surrounded small blood vessels where
inner walls were also covered by malignant cuboidal or
columnar cells with the tube-like structure named Schi-
ler-Duval bodies as the most distinctive histological fea-
ture. No metastasis was noticed in the liver and lung of
tumor-bearing mice.
TYST cells were mainly located between poorly differ-
entiated and undifferentiated state, of which the most
exhibited the embryonic or primordial ones, with many
glandular-like structures, large nucleus in oval shape,
nucleoli prominent, or reduction of intracellular orga-
nelles. TYST cells with microvillus structure were par-
tially differentiated into the epithelium-like cells
characterized by vacuolar goblet with mucus-like sub-
s t a n c e .O fT Y S Tc e l l s ,s o m ed ifferentiated well were
rich in intracellular organelles and nuclei stained deeply,
contained desmosomes, or had junction complexes.
There were abundant with rod-like crystals, mucus-like
substances and ribosomes in differentiated intestinal
epithelial cells, which indicated the active proliferation
and strong protein synthesis of cells. AFP could be
detected outside of cells, which represented the compo-
sure of electron dense material as basement membrane
material (Figure 1D).
Figure 2 demonstrated the expressions of AFP (A),
PLAP (B) and CK (C) in TYST tissue by immunohisto-
chemical staining. Values of average optical density of
AFP, PLAP and CK staining at 0.13 ± 0.08, 0.10 ± 0.06
and 0.13 ± 0.07 (n = 90-100 sections per staining),
respectively, were significantly higher than those in the
group without primary antibodies (0.04 ± 0.01). The
number of chromosomes with 34-48 and the modal
number 46 were consistent with the diploid structure in
tumors, different from those of mouse or human (Figure
2D). The breakage or loss was noted in some of
chromosomes.
Cloned cells of TYST were passed up to 25 genera-
tions with the stable growth and primary characteristics,
Figure 2 Histogram of the expressions of alpha- fetoprotein (A), placental alkaline phosphatase (B) and cytokeratins (C) in the tissue
formed from cloned testicular yolk sac tumor cells and stained by Immunohistochemistry. Chromosomes with the diploid structure in
cloned testicular yolk sac tumor cells (D). The origin magnification was × 400.
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of short spindle or polygon. Cells lost cell contact inhi-
bition and grew in the bundle toward the certain direc-
tion arranged with multiple overlapping growths (Figure
3A). Cells showed obvious heteromorphism and differ-
ent shapes in size (Figure 3B). Microvilli were noted on
the cell surface and the number of rough surfaced endo-
p l a s m i cr e t i c u l u ma n df r e er i b o s o m ei n c r e a s e d ,w h i l e
the number of mitochondria reduced. The nuclear
membrane in irregular shapes was edged by decreased
heterochromatin (Figure 3c and 3d).
Cloned TYST cell growth curve demonstrated that
there was a rapid growth of cells 2-4 days after the
culture, followed by a small and consistent growth
from 5 days and on (Figure 4A). Proliferation cycle
time of cloned cells was about 30 hours, during which
cloned cells were doubled. The number of cloned cell
chromosomes fluctuated from 39 to 97, and the modal
number was 46. There was no isochromosome of 12p,
i(12p) in G-banding, and some chromosomes in cloned
cells had abnormal structures similar to those in the
primary TYST cells (Figure 4B). Cloned cells had posi-
tive expression of AFP (Figure 4C), rather than b-hCG
(Figure 4D). DNA index of cloned cells was 1.3, as
compared with the normal range between 0.9 with 1.1.
DNA ploidy analysis showed aneuploidy, and DNA
cycle analysis showed that the G0-G1 accounted for
80% (normal value 80%), G2-M for 17.5% (normal
value 10%), and S phase for 2.5% (normal value 10%).
The purification rate of cloned TYS cells reached
about 60% in the 20th generation cells in double agar
for 14 days.
ATRA in the concentrations of 10
-7 M had significant
inhibitory effects on cell proliferation at 48 and 72
Figure 3 Cloned cells of testicular yolk sac tumors adhered and grew in the bundle toward the certain direction arranged with
multiple overlapping growths (A, × 100), obvious heteromorphism and different shapes in size with H&E staining (B, × 200). Microvilli
were noted on the cell surface between cells (C, × 8000), with the irregular nuclear (D, × 10000).
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0.05 and 0.01), 10
-6 M at 24, 48 and 72 hours (inhibitory
rates: 41, 53 and 80%, p < 0.01, respectively), or 10
-5 M
at 24, 48 and 72 hours (inhibitory rates: 46, 51 and 81%,
p < 0.01, respectively), as shown in Figure 5A. The
expression of RAR-b mRNA significantly increased from
48 hours and on as well as by time after the treatment
with ATPA at concentration of 10
-6 M( F i g u r e5 B )a n d
with the increased concentrations of ATRA at 48 hours
(Figure 5C).
Closed cells used for the measurement of cisplatin
effects were AFP-stained positive (Figure 6-A1). Kar-
yopyknosis, nuclei gradually shrank, or apoptotic
bodies of apoptotic cells was shown in Figure 6-A2.
As compared with those with vehicle (Figure 6-A3),
the number of TUNEL-positive cells increased 12
hours after the treatment with cisplatin (Figure 6-A4).
Apoptotic index significantly increased 12 (14.7 ± 3.4),
24 (20.2 ± 1.6), 48 (26.9 ± 3.4) and 72 hours (34.2 ±
3.6) after the co-culture with cisplatin, as compared
with that with vehicle (6.1 ± 1.8, p < 0.05 or 0.01,
respectively). The expression of p53 proteins increased
from 12 hours and on after the treatment with cis-
plantin (Figure 6-B2), whilet h ee x p r e s s i o no fB c l - 2
proteins decreased and re-distributed from 48 hours
(Figure 6-B4), as compared with those with vehicle
(Figure 6-B1 and 6-B3). Significance differences of
optimal density of p53 and Bcl-2 protein staining were
noticed 12 and 24 hours after cisplatin treatment, as
shown in Figure 6C and 6D, respectively. There were
significantly positive and negative correlations between
p53 and apoptotic index (r = 0.387, P = 0.006) and
between Bcl-2 and apoptotic index (r = -0.888, P =
0.000), respectively.
Discussion
Testicular germ cell tumors account for over 95% of all
testicular neoplasms and the incidence was doubled
worldwide over past decades up to 7.5/100,000 [13],
while pediatric germ cell tumors account for 60-75% of
pediatric testicular tumors [14], mostly as yolk sac
tumor. The in vivo tumor model by the subcutaneous
Figure 4 Cloned testicular yolk sac tumor cell growth curve during 8 day culture (A), with some abnormal chromosomes (B, X400), or
positive expression of alpha- fetoprotein (C, × 200), rather than beta-subunit human chorionic gonadotrophin (D, × 200).
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nient operation and easy observation [15]. The current
study established the TYST model by the passage from
the primary TYST cells to the 7th generation in total
95 nude mice during 15 months. The tumor formation
rate increased by the development of generations and
the average period of tumor formation was about 30
days, similar to pathological characteristics of human
TYST [16]. Even though, it is also a challenging to
establish the animal model to match the exact schedule
and nature of human tumor, which needs more and
further investigations. TYST cells were developed into
the phase between poorly differentiated and undifferen-
tiated states, with the embryonic or primordial activity.
We noted the local differentiation and growth of
human TYST cells from the columnar to glandular-like
or goblet cells-like cells, while few metastasis in the
TYST model. A number of animal models related to
TYST have been investigated and vary among the types
and mutations of tumor and its cells, e.g. animal model
of human disease based on yolk sac carcinoma (endo-
dermal sinus tumor) (49).
AFP was considered as a mark for the presence of YST,
which was initially found in the fetal yolk sac [17],
embryonic cells [18] and the gastrointestinal tract [19].
There was a clear correlation between AFP and malignant
germ cell tumor [20-23]. AF Pw a su s e da sam o n i t o r i n g
marker of closed TYST cells and formed in vivo tumor in
the resent study. Data from the present study demon-
strated that AFP proteins was expressed in isolated pri-
mary TYST cells, closed TYST cells, pre-transplanted
cells, and formed tumor in animals. In addition, we also
noted that TYST cells were positive to PLAP, which was
significantly over-expressed on the surface of various solid
Figure 5 Inhibitory effects of all-trans-retinoic acid (ATRA) at different concentrations on cell proliferation (A) measured by values of
the optimal density (OD) for 24, 48 and 72 hours, or the expression of RAR-b mRNA during 24-72 hours after the treatment with
ATPA at concentration of 10
-6 M (B) and treated with different concentrations of ATRA at 48 hours (c).
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tumor cells [25]. PLAP was also considered as a drug
design target for non-invasive cancer imaging and therapy
[26]. It indicates that the catalysis of the hydrolysis and
transphosphorylation of phosphate monoesters is involved
in the main metabolism of TYST cells. PLAP, as a classic
marker for germ cell tumors through combination of pla-
cental membrane glycoprotein with oligosaccharides phos-
phatidylinositol [24,27], was over-expressed in seminoma,
embryonal carcinoma and YST with about 90% positive
rate [28]. We also found that chromosomes for tumor
identification in each passage met nature of the primary
tumor, as previously reported [29].
We initially cloned and established the TYST cell line
confirmed by the histology, ultra-structure, growth
kinetics and expression of specific proteins and found
biological characteristics of cloned cells were similar to
the yolk sac tumor. Cloned cells also represented clear
microvilli on cell surfaces up to 25 generations, and pos-
sessed strong proliferation. The characteristic cytoge-
netic abnormality in adult testicular germ cell tumors is
the invariable gain of material from chromosome 12p
[30], so called isochromosome 12p, i(12p), measured by
both conventional cytogenetic and molecular cytogenetic
techniques, while the abnormal chromosome of i(12p)
hardly occurred in infants [31,32]. Our results on i(12p)
Figure 6 All closed cells used for the measurement of cisplatin effects were alpha- fetoprotein -stained positive (A1). Apoptotic cells
were detected with AO/EB staining (A2). Increased TUNEL-positive cells were detected 12 hours after the treatment with cisplatin (A4) or vehicle
(A3). The expression of p53 and Bcl-2 proteins was altered 12 hours and on after the treatment with vehicle (B1 and B3) or cisplantin (B2 and
B4), respectively. Values of optimal density of p53 (C) and Bcl-2 protein staining (D) were calculated during 12 and 72 hours after cisplatin
treatment.
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Page 10 of 12from the analysis of G-banding were similar to the find-
ings from previous studies [33].
ATRA as natural and synthetic derivatives of vitamin
A can bind to the nuclear receptors, involved in the reg-
ulation of embryonic development, organogenesis, cell
homeostasis, cell growth, differentiation and apoptosis
[34-37]. ATRA was used to treat and prevent various
types of human cancers and the sensitivity of cancer
cells to ATRA was considered as an indicator of the
development of ATRA resistance [38]. The cellular sen-
sitivity to ATRA was suggested to be increased upon
inactivation of SAG E3 ubiquitin ligase via genetic dele-
tion or pharmacological inhibition [36]. We found that
the concentration of ATRA at 10
-5 Mh a di n h i b i t o r y
effects of about 50% on TYST cell proliferation at 24
hours and 10
-7 M at 72 hours. It seems that TYST cells
were more sensitive to ATRA which had significantly
inhibitory effects on cell proliferation in the concentra-
tions of 10
-7 Ma t4 8h o u r sa n d1 0
-6 Ma t2 4h o u r s ,a s
compared with other cells, e.g. peripheral blood mono-
nuclear cells and CD4+ T cells (>10
-4 M [39]), human
A375 melanoma cells (>10
-5 M [40]), breast cancer cells
(> > 10
-5 M [41]), or small intestinal epithelium (>10
-5
M [42]). The further study is needed to confirm the var-
iation of drug sensitivity between different tumor cells.
The binding of ATRA with the receptor leads to altera-
tions of gene expressions, followed by a transport to the
nucleus and an activation of ATRA-associated signal
transduction [43]. We believe over-expression of ATRA
receptors on TYST cells may be responsible for the high
sensitivity of TYST cells to ATRA, while the binding of
ATRA per se could down-regulate the expression of the
receptor.
Cisplatin-based chemotherapy was recently proposed
to be an alternative of therapies for patients with germ
cell tumors, due to the early vascular toxicity of che-
motherapy in the endothelium and production of von
Willebrand factors [44]. It was also found that cisplatin
might have the direct effects on tumor cell to induce
DNA damage and activation of JNK/SAPK pathway
[45]. Data from the present study demonstrated that cis-
platin induced apoptosis of TYST cells through the acti-
vation of p53 expression and down-regulation of Bcl-
expression. Cisplatin could change the configuration of
P53, induce DNA damage, and inhibit cell proliferation
by blocking the cell cycle in G1 phase to apoptosis [46].
Cisplatin might change the distribution Bcl around the
nucleus or reduce the connection, transport, or forma-
tion of nuclear pore complex, and the maintenance of
the nuclear envelope, probably associated with the
development of cisplatin resistance in TYST cells
[47,48].
In conclusion, we cloned human TYST cells and
investigated pathological characteristics of cloned cells
in the in vitro and in vivo conditions, confirmed by the
histology, ultra-structure, growth kinetics and expression
of specific proteins and found biological characteristics
of cloned cells were similar to the yolk sac tumor.
Human TYST cells could be differentiated from the
columnar to glandular-like or goblet cells-like cells.
Chromosomes for tumor identification in each passage
met nature of the primary tumor. TYST cells were more
sensitive to ATRA. Cisplatin induced apoptosis of TYST
cells through the activation of p53 expression and
down-regulation of Bcl- expression. Thus, we believe
that cloned TYST cells and the animal model developed
are useful to understand the molecular mechanism of
TYST cells and screen new drug candidates for the
disease.
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